ACHE and early-onset autosomal dominant Alzheimer disease: A series of potent naphthalene-based AChE inhibitors were identified, synthesized, and evaluated for their in vitro and in vivo potentials against Alzheimer’s disease, in which one of these inhibitors is SF5 (Anwar et al., 2020).